Adjuvant SOX chemotherapy versus concurrent chemoradiotherapy after D2 radical resection of locally advanced esophagogastric junction (EGJ) adenocarcinoma: study protocol for a randomized phase III trial (ARTEG)

BACKGROUND: Survival benefit of adjuvant radiotherapy for locally advanced gastric cancer following gastrectomy plus D2 lymphadenectomy has always been controversial. Esophagogastric junction (EGJ) adenocarcinoma, which is usually classified as gastric cancer in East Asia, often has a higher locoreg...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Jinwen, Zhu, Xiu, Du, Yian, Zhu, Yuan, Yu, Pengfei, Yang, Litao, Xu, Zhiyuan, Huang, Ling, Zhang, Yunli, Zhang, Yanqiang, Liu, Luying, Cheng, Xiangdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556914/
https://www.ncbi.nlm.nih.gov/pubmed/34717717
http://dx.doi.org/10.1186/s13063-021-05617-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556914/
https://www.ncbi.nlm.nih.gov/pubmed/34717717
http://dx.doi.org/10.1186/s13063-021-05617-7

Ejemplares similares